All terms in DRUGBANK

Label Id Description
Deutivacaftor DB15141 [Deutivacaftor is under investigation in clinical trial NCT03227471 (A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis).]
Altropane I-123 DB15144 [Altropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes).]
PF-06650833 DB15143 [PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects).]
Bempegaldesleukin DB15140 [Bempegaldesleukin is under investigation in clinical trial NCT03729245 (A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)).]
R-Styrene Oxide DB04499
Nicotinamide adenine dinucleotide cyclohexanone DB03168
(S)-Hmg-Coa DB03169
2'-Monophosphoadenosine-5'-Diphosphoribose DB04497
Acetic acid DB03166 [Acetic acid is a product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed) Acetic acid otic (for the ear) is an antibiotic that treats infections caused by bacteria or fungus.]
Pentabromophenol DB03167
Aspartate Semialdehyde DB04498
Propyl alcohol DB03175 [A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.]
KB-141 DB03176 [An anticholesteremic agent.]
CRA_10433 DB03173
Phosphonoacetaldehyde DB03174
Indole-3-Propanol Phosphate DB03171
Tubercidin DB03172 [An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.]
Dephospho Coenzyme A DB03170
Voruciclib DB15157 [Voruciclib is under investigation in clinical trial NCT03547115 (A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML).]
ABT-072 DB15156 [ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C).]